ReposiTrak, Inc.
NYSEReposiTrak reported Q3 FY2026 results yesterday after the bell — and the print landed squarely in the middle of a story that had been building for weeks around short positioning, a CEO selling programme, and a stock price that had recovered sharply from its February lows. Short sellers have been quietly adding pressure through the month. Short interest climbed nearly 9% over the…
Snapshot as of 29 Jun 2026
ReposiTrak reported Q3 FY2026 results yesterday after the bell — and the print landed squarely in the middle of a story that had been building for weeks around short positioning, a CEO selling programme, and a stock…
ReposiTrak enters its May 14 earnings window with a notable contradiction: the stock has surged 9% in a week and 24% over the past month to $8.87, while a meaningful short position has been slowly unwinding from its…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TRAK — free to start on ORTEX.
Sign up for free →Open TRAK on ORTEX